Co-cure sent this out today. It won't help ampligen at all.
Dyer & Berens LLP files class action lawsuit against Hemispherx Inc.[/URL] - HEB Marketwire October 10, 2009
islandfinn
Dyer & Berens LLP files class action lawsuit against Hemispherx Inc.[/URL] - HEB Marketwire October 10, 2009
The complaint alleges that, during the Class Period, defendants
misled investors regarding the status of Hemispherx's New Drug
Application ("NDA") for Ampligen with the U.S. Food and Drug
Administration ("FDA"). Specifically, defendants failed to disclose
and misrepresented the fact that the FDA had requested several
reports from the Company before the NDA could even be considered,
thus delaying the possible approval of Ampligen by several months
at a minimum. On November 2, 2009, when the Company belatedly
disclosed this information, the per share price of Hemispherx's
common stock dropped from $1.45 on the previous day to $1.13, a
drop of more than 20%. The next day, one commenter characterized
the November 2nd Company "update" as essentially an admission
"that its prior public statements were false and misleading."
islandfinn